Literature DB >> 3195590

Pyridoxine effects on ornithine ketoacid transaminase activity in fibroblasts from carriers of two forms of gyrate atrophy of the choroid and retina.

V E Shih1, R Mandell, E L Berson.   

Abstract

Gyrate atrophy of the choroid and retina that is due to ornithine ketoacid transaminase (OKT) deficiency is an autosomal recessive disorder. Fibroblasts from heterozygotes for the pyridoxine-responsive variant as well as those for the pyridoxine-nonresponsive variant contain intermediate levels of OKT activity. These two variants can be distinguished by the in vitro responsiveness of OKT activity to pyridoxal phosphate (PLP) stimulation. The ratios of OKT activity at 0.04 mM PLP compared with activity at 0 mM PLP were, respectively, lowest for controls (1.18 +/- 0.18; N = 12), intermediate for pyridoxine-nonresponsive heterozygotes (1.43 +/- 0.26; N = 5), and highest for pyridoxine-responsive heterozygotes (2.20 +/- 0.14; N = 3).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3195590      PMCID: PMC1715599     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  11 in total

1.  Gyrate atrophy of the choroid and retina associated with hyperornithinaemia.

Authors:  K Takki
Journal:  Br J Ophthalmol       Date:  1974-01       Impact factor: 4.638

2.  Chemical, physical, and morphological properties of ornithine Aminotransferase from rat liver.

Authors:  C Peraino; L G Bunville; T N Tahmisian
Journal:  J Biol Chem       Date:  1969-05-10       Impact factor: 5.157

3.  A two year trial of low protein, low arginine diets or vitamin B6 for patients with gyrate atrophy.

Authors:  E L Berson; A H Hanson; B Rosner; V E Shih
Journal:  Birth Defects Orig Artic Ser       Date:  1982

4.  Clinical and biochemical heterogeneity in gyrate atrophy.

Authors:  M I Kaiser-Kupfer; D Valle; A J Bron
Journal:  Am J Ophthalmol       Date:  1980-02       Impact factor: 5.258

5.  Gyrate atrophy with hyperornithinaemia: different types of responsiveness to vitamin B6.

Authors:  S Hayasaka; T Saito; H Nakajima; Y Takaku; T Shiono; K Mizuno; K Ohmura; K Tada
Journal:  Br J Ophthalmol       Date:  1981-07       Impact factor: 4.638

6.  Molecular basis of ornithine aminotransferase deficiency in B-6-responsive and -nonresponsive forms of gyrate atrophy.

Authors:  V Ramesh; A I McClatchey; N Ramesh; L A Benoit; E L Berson; V E Shih; J F Gusella
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  Ornithine ketoacid transaminase deficiency in gyrate atrophy of the choroid and retina.

Authors:  V E Shih; E L Berson; R Mandell; S Y Schmidt
Journal:  Am J Hum Genet       Date:  1978-03       Impact factor: 11.025

8.  Ocular and biochemical abnormalities in gyrate atrophy of the choroid and retina.

Authors:  E L Berson; S Y Schmidt; V E Shih
Journal:  Ophthalmology       Date:  1978-10       Impact factor: 12.079

9.  Reduction of hyperornithinemia with a low protein, low arginine diet and pyridoxine in patients with a deficiency of ornithine-ketoacid transaminase (OKT) activity and gyrate atrophy of the choroid and retina.

Authors:  V E Shih; E L Berson; M Gargiulo
Journal:  Clin Chim Acta       Date:  1981-07-01       Impact factor: 3.786

10.  Quaternary structure of ornithine aminotransferase in solution and preliminary crystallographic data.

Authors:  Z Marković-Housley; M Kania; A Lustig; M G Vincent; J N Jansonius; R A John
Journal:  Eur J Biochem       Date:  1987-01-15
View more
  1 in total

1.  CRISPR correction of the Finnish ornithine delta-aminotransferase mutation restores metabolic homeostasis in iPSC from patients with gyrate atrophy.

Authors:  Rocio Maldonado; Sami Jalil; Timo Keskinen; Anni I Nieminen; Mervi E Hyvönen; Risto Lapatto; Kirmo Wartiovaara
Journal:  Mol Genet Metab Rep       Date:  2022-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.